Agradecimentos: CAH is funded by the Australian Red Cross Blood Service and acknowledges the Australian Governments that fund the Blood Service for provision of blood, blood products and services to the Australian Community. WAF is supported by the Intramural Research Program (project ID Z99...

Agradecimentos: CAH is funded by the Australian Red Cross Blood Service and acknowledges the Australian Governments that fund the Blood Service for provision of blood, blood products and services to the Australian Community. WAF is supported by the Intramural Research Program (project ID Z99 CL999999) of the NIH Clinical Center. TP is supported by the Laboratoire d'Excellence GR‐Ex for exome sequencing studies and especially acknowledges Pr Olivier Hermine, Head of this consortium

The International Society of Blood Transfusion (ISBT) Working Party for Red Cell Immunogenetics and Blood Group Terminology meets in association with the ISBT congress and has met three times since the last report: at the international meetings held in Dubai, United Arab Emirates, September 2016 and...

The International Society of Blood Transfusion (ISBT) Working Party for Red Cell Immunogenetics and Blood Group Terminology meets in association with the ISBT congress and has met three times since the last report: at the international meetings held in Dubai, United Arab Emirates, September 2016 and Toronto, Canada, June 2018; and at a regional congress in Copenhagen, Denmark, June 2017 for an interim session. As in previous meetings, matters pertaining to blood group antigen nomenclature and classification were discussed. New blood group antigens were approved and named according to the serologic and molecular evidence presented. Fifteen new blood group antigens were added to eight blood group systems. One antigen was made obsolete based on additional data. Consequently, the current total of blood group antigens recognized by the ISBT is 360, of which 322 are clustered within 36 blood groups systems. The remaining 38 antigens are currently unassigned to a known system. Clinically significant blood group antigens continue to be discovered, through serology/sequencing and/or recombinant or genomic technologies

Fechado